Search Results

You are looking at 61 - 70 of 96 items for :

  • "skin cancer" x
Clear All
Full access

Stephen G. Bown

of PDT in skin cancer and precancer and possibly Barrett esophagus, but only poorly documented results were available for most of the other oncologic indications. A workshop of PDT clinicians in the United Kingdom was called for to assess the value of

Full access

Philip L. McCarthy

the lenalidomide arm of both studies. An event-free survival (EFS) analysis that included disease progressions, deaths, and SPMs (excluding nonmelanoma skin cancers) as events showed a superior EFS for the lenalidomide arms in both studies ( Table 2

Full access

Katy K. Tsai, Neharika Khurana, Timothy McCalmont, Adil Daud, Boris Bastian and Iwei Yeh

profiling was instrumental in correctly diagnosing clear cell BCC and in identifying rational treatment options for metastatic disease. Case Report A 51-year-old man presented to the UCSF Melanoma and Skin Cancer Program in June 2015 with a rapidly enlarging

Full access

Jesse D. Troy, Carlos M. de Castro, Mary Ruth Pupa, Greg P. Samsa, Amy P. Abernethy and Thomas W. LeBlanc

prior history of cancer other than basal/squamous cell skin cancers (40 cancers reported among 36 Table 1. Patient Characteristics patients). Approximately half (48.4%) had low-risk disease, and 5 (4.0%) experienced disease progression to

Full access

Matthew G. Fury, Eric Sherman, Donna Lisa, Neeraj Agarwal, Kenneth Algazy, Bruce Brockstein, Corey Langer, Dean Lim, Ranee Mehra, Sandeep K. Rajan, Susan Korte, Brynna Lipson, Furhan Yunus, Tawee Tanvetyanon, Stephanie Smith-Marrone, Kenneth Ng, Han Xiao, Sofia Haque and David G. Pfister

, uncontrolled central nervous system metastases, or other active invasive malignancies (other than nonmelanoma skin cancers or in situ cervical cancer). Study Design This was a multicenter, open-label, randomized, phase II study for patients with

Full access

Adam L. Cohen and John H. Ward

radiation therapy in women with HER2-positive DCIS in the NSABP B-43 trial. The primary end point of this trial is prevention of ipsilateral breast events, including breast cancer, skin cancer, and DCIS. The proposed sample size of 2000 patients should give

Full access

Michael D. Green and James A. Hayman

for high-risk and locally advanced skin cancer . Radiat Oncol J 2016 ; 34 : 145 – 155 . 38. Foote M Harvey J Porceddu S . Effect of radiotherapy dose and volume on relapse in Merkel cell cancer of the skin . Int J Radiat Oncol Biol Phys

Full access

Vishwajith Sridharan, Vinayak Muralidhar, Danielle N. Margalit, Roy B. Tishler, James A. DeCaprio, Manisha Thakuria, Guilherme Rabinowits and Jonathan D. Schoenfeld

Buster K Sanchez M . Skin cancer and photoprotection in people of color: a review and recommendations for physicians and the public . J Am Acad Dermatol 2014 ; 70 : 748 – 762 . 27 Iyer JG Storer BE Paulson KG . Relationships among primary

Full access

Talia Golan and Milind Javle

with the autosomal recessive disorder xeroderma pigmentosum, who are at an increased risk of developing skin cancer, have difficulty in repairing UV light–related DNA damage. It was later demonstrated that the specific defect in this case resulted from

Full access

Rondi M. Kauffmann, Leanne Goldstein, Emily Marcinkowski, George Somlo, Yuan Yuan, Philip H.G. Ituarte, Laura Kruper, Leslie Taylor and Courtney Vito

system provides detailed data on all patients diagnosed and/or treated for any primary malignancy (excluding nonmelanoma skin cancers) in the state of California. Information reported includes patient age, sex, race/ethnicity, insurance status